Dermabrasion Versus Microneedling in Transplantation of Autologous Noncultured Melanocyte-Keratinocyte Cell Suspension in Patients With Vitiligo

Dermatol Surg. 2023 May 1;49(5):494-502. doi: 10.1097/DSS.0000000000003738. Epub 2023 Mar 8.

Abstract

Background: Autologous noncultured melanocyte-keratinocyte transplantation is one of the procedures used to treat stable vitiligo with varying reported results. Recipient site preparation is one of the variables that could affect repigmentation outcomes.

Objective: To assess the effectiveness of transplanting autologous melanocyte-keratinocyte suspension in patients with stable vitiligo and to compare recipient site preparation using dermabrasion versus microneedling.

Methods: From March 2020 to September 2022, this randomized comparative study included 40 patients with 40 stable vitiligo lesions managed by suspension transplants of melanocytes. Patients were divided into 2 groups: group A, where the recipient site was prepared using dermabrasion, and group B, which was done by microneedling. The assessment was performed 3 months after the treatment based on the degree of repigmentation (excellent, ≥90%; good, 50%-89%; fair, 20%-49%; and poor response, <20%).

Results: Both modalities resulted in effective repigmentation, but the dermabrasion group showed a statistically significant improvement and a satisfactory repigmentation rate.

Conclusion: Autologous melanocyte transplantation is a safe and effective treatment method for stable vitiligo lesions that have not responded to other therapies. When compared with microneedling, dermabrasion produced better outcomes for recipient site preparation.

Publication types

  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Dermabrasion
  • Humans
  • Keratinocytes / transplantation
  • Melanocytes / transplantation
  • Suspensions
  • Transplantation, Autologous / methods
  • Treatment Outcome
  • Vitiligo* / surgery

Substances

  • Suspensions